Current Trends in Multiple Myeloma: Customizing Treatment Strategies and Optimizing Outcomes
Thomas Chauncey, MD and Nikhil Munshi, MD (Program Chairs) and other multiple myeloma experts are presenting a series of live 1-hour CME/CE accredited activities that are designed to help healthcare providers in VA/DoD Centers better understand best practice approaches to utilizing all the current and new therapies in multiple myeloma to ensure optimal patient outcomes.
***To arrange to have one of the faculty present this program at your Center, please click on the Request a Meeting button and complete the form. One of our project managers will contact you to assist with scheduling your program***
***CLICK HERE TO REQUEST A PROGRAM***
*Flexible meeting formats that can be held at a VA/DoD Center or at an off-site location
*No fee to schedule or attend an activity
*All activities will be accredited by Rush University CME Department for physicians, nurses, pharmacists (other accreditations are available)
*We will work with your hospital's CME department and/or Medical Staff Office to obtain the necessary permissions to schedule the activity
1.Discuss the unique mechanisms of action of promising novel agents in the treatment of multiple myeloma
2.Develop a personalized treatment approach in the frontline setting considering patient characteristics and risk profile
3.Devise optimal evidence-based strategies for individualized treatment of patients that are relapsed/refractory to initial treatment
4.Describe the latest clinical data and predictive measures available for determining risk stratification and personalizing patient management
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity is being presented without bias and with commercial support.
Current Trends in Multiple Myeloma: Customizing Treatment Strategies and Optimizing Outcomes is eligible for one (1) ONCC/ILNA recertification points in the following categories: Scientific Basis for Practice; Treatment Modalities.
Rush University Medical Center designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University Medical Center designates this live activity for a maximum of one (1) continuing nursing education credit(s).
Rush University Medical Center designates this live activity for a maximum of one (1) continuing education unit(s) in Pharmacy.